MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Association between Smoking and LRRK2 Variants on Parkinson’s Disease Risk

    JDJ. Wang, LL. Chan, E. Ng, KM. Prakash, L. Tan, EK. Tan (Singapore, Singapore)

    Objective: To examine whether smoking modifies the association between protective LRRK2 variants (N551K and R1398H) and the risk of Parkinson’s disease in a case-control cohort.…
  • 2026 International Congress

    Subcutaneous Levodopa Infusion in Multiple System Atrophy: a Case Series

    A. Aldaz Burgoa, C. Ribacoba Díaz, A. Fernández Revuelta, E. López Valdés, R. García-Ramos García (Madrid, Spain)

    Objective: To describe safety, tolerability and clinical response to continuous subcutaneous (SC) levodopa infusion in three patients with multiple system atrophy (MSA). Background: Response to…
  • 2026 International Congress

    Machine Learning-Driven Analysis of Epigenetic Signatures in Juvenile Huntington’s Disease: Investigating Histone Modification Dynamics

    R. Kumar, S. Choudhary, M. Singh (Pharmacology, India)

    Objective: To investigate the role of histone modifications in Juvenile Huntington’s Disease (JHD) using machine learning, aiming to identify novel epigenetic biomarkers predictive of disease…
  • 2026 International Congress

    Impact of Hula on Balance Outcomes in Parkinson’s Disease

    M. Yee, P. Young, R. Shuman, C. Stickley, M. Bruno (Honolulu, USA)

    Objective: This study aims to determine the impact of a 12-week Hula program on balance in patients with Parkinson’s Disease (PD) and to investigate changes…
  • 2026 International Congress

    Caffeine and Tobacco Exposure and the Presence of Levodopa-Induced Dyskinesia (LID) in the STAT-PD Trial

    A. Clarke, B. Lobb, K. Chung (Portland, USA)

    Objective: Using data from the STAT-PD trial, ClinicalTrials NCT # 4064294, we examined whether lifetime caffeine and nicotine exposure are associated with the presence and…
  • 2026 International Congress

    Levodopa-induced peak-dyskinesia and motor fluctuations in corticobasal syndrome

    N. Caballol, A. Cámara, L. Planellas, C. Painous, A. Peral, A. Planas-Ballvé, P. Lombardo, A. ávila, Y. Compta (Sant Joan Despí, Spain)

    Objective: Describe two corticobasal syndrome (CBS) cases presenting with levodopa-induced dyskinesia (LID), one with motor fluctuations (MFs). Background: CBS is a rare neurodegenerative syndrome characterized…
  • 2026 International Congress

    Brain Atlas-Based Machine Learning for Parkinsonian Disorders Classification and Evaluation of Classification Performance Across Disease Duration

    S. Kim, S. Oh, H. Yoo, W. Kim, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: To evaluate the diagnostic performance of a multi-atlas MRI–based machine learning model for differentiating degenerative parkinsonian disorders and to examine how classification accuracy varies…
  • 2026 International Congress

    Effect of ApoE ε4 allele on brain metabolism and cognition in non-demented Parkinson’s disease

    JH. Lee, YH. Ryu, CH. Lyoo, HS. Yoo (Seoul, Republic of Korea)

    Objective: This study aimed to explore the interplay between Apolipoprotein E (ApoE) ε4 allele, brain metabolism, and cognition in non-demented Parkinson’s disease (PD) patients. Background:…
  • 2026 International Congress

    18F-FD4 PET Reveals α-Synuclein Deposition and Clinical Correlations in Parkinson’s Disease

    JW. Wang (Shanghai, China)

    Objective: This study aimed to determine the potential of a novel α-syn tracer, 18F-FD4 PET, to track regional α-synuclein deposition in PD and explore its…
  • 2026 International Congress

    Incidence and Outcomes of Hip Fractures in Parkinsonism vs Non-Parkinson Population: A Systematic Review of the Literature

    U. Saini (Chandigarh, India)

    Objective: To assess hip fractures incidence in Parkinsonism patients and assess their outcome. Background: Parkinson's disease is associated with gait disturbance, postural instability, and increased…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley